Skip to content
Home/Companies/HealthTech/Sympatient
Sympatient

Sympatient

HealthTech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Sympatient?

Sympatient is a German HealthTech company, currently owned by IFB Innovationsstarter since 2020.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
IFB Innovationsstarter
Investor
IFB Innovationsstarter
Innovationsstarter Fonds Hamburg II · 2017 · VC

Key facts

HQGermany
SectorHealthTech
StatusActive
Websitesympatient.com

More from Innovationsstarter Fonds Hamburg II

Other portfolio companies in the same fund.

Bluu Seafood
Active
FoodTechGermany· 2020
LignoPure
LignoPure
Active
IndustrialsGermany· 2019
MindPeak
Active
HealthTechGermany· 2019
Resourcify
Active
SoftwareGermany· 2018
HQLabs
Exited 2022
SoftwareGermany· 2017
to BID Equity
KSK Diagnostics
Exited 2018
MedTechGermany· 2017
to Bosch Healthcare Solutions

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Sympatient?

Sympatient is currently owned by IFB Innovationsstarter, through Innovationsstarter Fonds Hamburg II, since 2020.

When did IFB Innovationsstarter acquire Sympatient?

IFB Innovationsstarter acquired Sympatient in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue